Degenerative Disc Disease Treatment Market Trends Research & Projections for 2017–2025
Degenerative disc disease is a spinal condition caused by the breakdown of your intervertebral discs. The symptoms observed for degenerative disc disease are tingling or numbness in legs or difficulty walking. This disease is diagnosed with physical examination, through X-rays or magnetic resonance imaging (MRI). The degenerative disc disease is most commonly seen in geriatric population and a cause of low back pain and neck pain in adults. The common cases of back pain among patients occurs at the lower side of the back and is known as lower back pain. As per American Association of Neurological Surgeons in 2016, 75-85% of people in the U.S. experience some form of back pain in their life.
Furthermore, depending upon the level of pain, degenerative disc disease can be treated by two common process which includes non-surgical and spinal fusion. The non-surgical treatments include medications, physical therapy and chiropractic care. Whereas, spinal fusion is a procedure used to surgically treat degenerative disc disease.
Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/1280
Recent advances in technology is expected to favor the growth of degenerative disc disease treatment market in near future.
The recent advances in technology helps the degenerative disc disease treatment market to augment in near future. For instance, in 2016, according to data published in Journal of Neurosurgery: Spine, the ProDisc technology has proven clinical efficacy in the U.S. It was also found. Authors of the study found total disc replacement with ProDisc-C that the procedure is also cost-effective compared to spinal fusion and recorded an average of US $12,789 in savings which is more effective than spinal fusion for single-level procedures.
In addition to this, the manufacturers are also focusing on acquisition to adopt and strengthen the company’s product portfolio. For instance, Centinel Spine in October 2017, has entered into an asset purchase agreement to acquire the ProDisc Total Disc Replacement portfolio from DePuy Synthes. This acquisition will provide a complete platform of ProDisc technologies to Centinel Spine, which include, ProDisc-C, Discover, ProDisc-L, ProDisc-C Nova, ProDisc-C Vivo, and ProDisc-Oblique.
North America is expected to be dominant in the global degenerative disc disease treatment market over the forecast period
North America market accounted for the largest share in the degenerative disc disease treatment market, followed by Europe market in 2016. This is attributed due to increasing number of clinical trials in U.S. for degenerative disc disease treatment. For instance, Centinel Spine is planning to commence clinical trials with the Nova, Vivo and Oblique technologies, currently sold outside of the U.S.
In December 2017, Camber Spine announced that this company has received U.S. Food and Drug Administration (FDA) clearance to market its SPIRA-C, Open Matrix Cervical Interbody device. This clearance marks Camber’s second implant clearance in the SPIRA family of implant systems to be released in the U.S. market, indicated for use at one or two contiguous levels in the cervical spine, in skeletally mature patients who have had six weeks of non-operative treatment for the degenerative disk disease (DDD) with up to Grade 1 spondylolisthesis.
Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1280
Furthermore, the Spinal Kinetics, Inc., the designer and manufacturer of the M6 artificial disc, announced in June 2017, that the total implantations of the company’s M6-C Cervical and M6-L Lumbar discs have exceeded 50,000 throughout the international markets where the M6 is commercially available. This fact supports the growing demand of degenerative disc disease treatment market.
Key players operating in the global degenerative disc disease treatment market includes Medtronic Plc, Zimmer Biomet, Paradigm Spine, Globus Medical, Cousin Biotech, Ulrich Medical and SpineVision.
You may be interested
Researchers Demonstrate Quantum Walk in Bose-Einstein CondensateMohit Joshi - October 20, 2018
Researchers from Oklahoma State University manipulated the momenta of ultra-cold atoms to demonstrate a quantum walk Quantum analogs of a random walk form the basics of proposed…
Mobile Health Apps and Solutions Market Industry Insights, Dynamic Growth and Revenue Forecast 2018-2026Albert R - October 19, 2018
Mobile Health Apps and Solutions Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of…
Drug Abuse Treatment Market – Launch and approval of novel drugs is projected to fuel market growth over the forecast periodMohit Joshi - October 19, 2018
Coherent Market Insights released a new market study on 2018-2026 Drug Abuse Treatment Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages…